OBJECTIVE
To assess the prevalence of diabetes and its risk factors.
DESIGN
Population based, cross sectional study.
SETTING
31 provinces in mainland China with nationally representative cross sectional data from 2015 to 2017.
PARTICIPANTS
75 880 participants aged 18 and older-a nationally representative sample of the mainland Chinese population.
MAIN OUTCOME MEASURES
Prevalence of diabetes among adults living in China, and the prevalence by sex, regions, and ethnic groups, estimated by the 2018 American Diabetes Association (ADA) and the World Health Organization diagnostic criteria. Demographic characteristics, lifestyle, and history of disease were recorded by participants on a questionnaire. Anthropometric and clinical assessments were made of serum concentrations of fasting plasma glucose (one measurement), two hour plasma glucose, and glycated haemoglobin (HbA(1c)).
RESULTS
The weighted prevalence of total diabetes (n=9772), self-reported diabetes (n=4464), newly diagnosed diabetes (n=5308), and prediabetes (n=27 230) diagnosed by the ADA criteria were 12.8% (95% confidence interval 12.0% to 13.6%), 6.0% (5.4% to 6.7%), 6.8% (6.1% to 7.4%), and 35.2% (33.5% to 37.0%), respectively, among adults living in China. The weighted prevalence of total diabetes was higher among adults aged 50 and older and among men. The prevalence of total diabetes in 31 provinces ranged from 6.2% in Guizhou to 19.9% in Inner Mongolia. Han ethnicity had the highest prevalence of diabetes (12.8%) and Hui ethnicity had the lowest (6.3%) among five investigated ethnicities. The weighted prevalence of total diabetes (n=8385) using the WHO criteria was 11.2% (95% confidence interval 10.5% to 11.9%).
CONCLUSION
The prevalence of diabetes has increased slightly from 2007 to 2017 among adults living in China. The findings indicate that diabetes is an important public health problem in China.
[1]China Med Univ, Hosp 1, Dept Endocrinol & Metab, 155 Nanjing Bei St, Shenyang 110001, Liaoning, Peoples R China.
[2]China Med Univ, Hosp 1, Inst Endocrinol, 155 Nanjing Bei St, Shenyang 110001, Liaoning, Peoples R China.
[3]Zhengzhou Univ, Affiliated Hosp 1, Div Endocrinol, Dept Internal Med, Zhengzhou, Henan, Peoples R China.
[4]Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanning, Guangxi, Peoples R China.
[5]Hainan Gen Hosp, Dept Endocrinol, Haikou, Hainan, Peoples R China.
[6]Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Endocrinol, Xian, Shannxi, Peoples R China.
[7]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Endocrinol, Wuhan, Hubei, Peoples R China.
[8]Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China.
[9]Third Mil Med Univ, Southwest Hosp, Dept Endocrinol, Chongqing, Peoples R China.
[10]Dalian Med Univ, Affiliated Hosp 1, Dept Endocrinol, Dalian, Liaoning, Peoples R China.
[11]Ningxia Med Univ, Cardiovasc & Cerebrovascuhr Dis Hosp, Dept Endocrinol, Yinchuan 750004, Ningxia, Peoples R China.
[12]Nanchang Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Nanchang, Jiangxi, Peoples R China.
[13]Harbin Med Univ, Affiliated Hosp 1, Dept Endocrinol, Harbin, Hellongjiang, Peoples R China.
[14]Hohhot First Hosp, Dept Endocrinol, Hohhot, Inner Mongolia, Peoples R China.
[15]Cent South Univ, Xiangya Hosp 2, Dept Endocrinol & Metab, Changsha, Hunan, Peoples R China.
[16]Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Res Ctr Endocrine & Metab Dis, Nanjing, Jiangsu, Peoples R China.
[17]Fujian Med Univ Union Hosp, Fujian Inst Endocrinol, Dept Endocrinol & Metab, Fuzhou, Fujian, Peoples R China.
[18]Lanzhou Univ, Hosp 1, Dept Endocrinol, Lanzhou, Gansu, Peoples R China.
[19]Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Endocrinol & Metab, Chengdu, Sichuan, Peoples R China.
[20]Jilin Univ, Hosp 1, Dept Endocrinol & Metab, Changchun, Min, Peoples R China.
[21]Shanghai Univ Med & Hlth Sci, Affiliated Zhoupu Hosp, Dept Endocrinol, Shanghai, Peoples R China.
[22]Anhui Med Univ, Hosp 1, Dept Endocrinol, Hefei, Anhui, Peoples R China.
[23]First Peoples Hosp Yunnan Prov, Dept Endocrinol, Kunming, Yunnan, Peoples R China.
[24]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Endocrinol & Metab, Guangzhou, Guangdong, Peoples R China.
[25]Shanxi Med Univ, Hosp 1, Dept Endocrinol, Taiyuan, Shanxi, Peoples R China.
[26]Peoples Hosp Tibet Autonomous Reg, Dept Endocrinol & Metab, Lhasa, TN, Peoples R China.
[27]Qinghai Prov Peoples Hosp, Dept Endocrinol, Xining, Qinghai, Peoples R China.
[28]Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.
[29]Guiyang Med Univ, Affiliated Hosp, Dept Endocrinol & Metab, Guiyang, Guizhou, Peoples R China.
[30]Hebei Med Univ, Hosp 2, Dept Endocrinol, Shijiazhuang, Hebei, Peoples R China.
[31]Xinjiang Med Univ, Affiliated Hosp 1, Dept Endocrinol, Urumqi, Xinjiang, Peoples R China.
[32]Tianjin Med Univ Gen Hosp, Dept Endocrinol & Metab, Tianjin, Peoples R China.
[33]Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China.
[34]Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Inst Endocrinol, Shanghai, Peoples R China.
[35]Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China.
(8.0+极速模式)